Design And Rationale Of Effisayil 1, A Phase Ii, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Of Spesolimab In Patients With Generalized Pustular Psoriasis With An Acute Flare
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要